TOKYO - Fujifilm Holdings Corp. is considering restarting a clinical trial in Japan for its anti-viral drug Avigan in treating COVID-19 patients, company sources said Sunday, after the government held off approval of the drug late last year.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
